BIOTREND Signs Distribution Agreement with 3D Biomatrix
The Perfecta3D(TM) Hanging Drop Plates will be available at BIOTREND Chemikalien GmbH in Germany and Switzerland
(firmenpresse) - About the Companies
BIOTREND Chemikalien GmbH provides more than 80,000 products to the life science community, focusing on biochemical, immunochemical and pharmaceutical research. Founded in 1988, BIOTREND provides a high-quality, cost-effective products.
http://www.biotrend.com
3D Biomatrix, LLC is a life sciences company developing and marketing revolutionary solutions for three dimensional (3D) cell cultures. Cells grown on 3D Biomatrix products have been shown to retain a much higher complexity of body response than cells grown in traditional two-dimensional plates and flasks.
http://www.3dbiomatrix.com
3D Biomatrix, which develops and sells tools for drug discovery research and testing that mimic the human cellular environment, has signed agreements for the distribution of Hanging Drop Plates with distributors that serve the United States, the United Kingdom, Ireland, Germany, Switzerland, and South Korea.
Ann Arbor, MI (PRWEB) September 13, 2011
3D Biomatrix, a leader in the development of three-dimensional (3D) cell culture products, has signed distribution agreements with five prominent life science research product distributors in the US, Europe, and Asia, to market and sell the company’s Perfecta3D(TM) Hanging Drop Plates. The Hanging Drop Plates are designed to simplify and streamline spheroid formation, culture, and subsequent testing of the 3D cellular constructs. Spheroid cultures grown in Perfecta3D(TM) Hanging Drop Plates allow drug discovery researchers to easily mimic tissue metabolic and proliferative gradients, to capture complex cell-matrix and cell-cell interactions, and to monitor cell growth easily and regularly.
"These distributors represent major markets around the globe for 3D Biomatrix,” said Laura Schrader, CEO of 3D Biomatrix. “Working with the right partners is essential to serving laboratory researchers in these regions, so we are delighted to have these new relationships and look forward to success with our new partners in the years to come."
Meghan Cuddihy, Distribution Manager at 3D Biomatrix, added, “The level of interest our products have received around the world reflects the importance of 3D cell culture products in stem cell research, cancer research, and drug discovery.”
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
After more than a decade of experience in the sale and marketing of research products for “Life Science Research”, Werner Hassler, Switzerland and Gunther Jaeger, Germany founded the Cologne based BIOTREND Chemikalien GmbH in May 1988.
BIOTREND was instigated in order to meet the growing demand from customers for an independent and technologically orientated distribution facility offering high quality, yet cost-effective products for biochemical, immunochemical and pharmaceutical research.
Through our innovative strength we are not only providing our customers a vast product range, but also a high quality, first-class service package.
At present we offer more than 65.000 products that have successfully been implemented not only in the drug discovery market, but also in cancer research as well as other scientific fields.
Datum: 16.09.2011 - 09:40 Uhr
Sprache: Deutsch
News-ID 1038149
Anzahl Zeichen: 0
contact information:
Contact person: Herr Jaeger
Town:
Koeln
Phone: 0221-9498320
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BIOTREND Signs Distribution Agreement with 3D Biomatrix
"
steht unter der journalistisch-redaktionellen Verantwortung von
BIOTREND Chemikalien GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
